Overview > 항암유효성평가지원센터

The importance of pre-clinical efficacy evaluation in the early stage of drug development has been proven in successful drug development and clinical trial design. APEX ha s established a wide range of translational research portfolios to meet your needs.

In addition to various traditional evaluation models, we provide comprehensive preclinical drug efficacy pharmacology research, including evaluation models using patient-derived samples, advanced animal imaging analysis, toxic pathology, biomarkers, DMPK analysis, PK/PD modeling, and consulting services.

Consumer-Centered market Customized Services

High-difficulty efficacy evaluation specialized for cancer disease


Non-Clinical + Clinical One-Stop Service


Quality Assurance System

To provide highly quality results, we are continuously making efforts at the center level, including strict cell line management, protocol management, and internal/external training.


Operation Policy

Establishment of global licensing documentation through technical partnerships with our global clinical trial center and global leading institutions


Global Coverage Service through application of the International Common Technical Document (CTD) system

Establish a quality improvement system to strictly manage service quality and continuously improve quality


Monitor and improve service quality through verification of each validation test method

Share real-time progress and test results through online assignment management function


Customized test analysis through real-time discussion

QA operation under the direct control of the center director


Validation of SOP through QA inspection


All tests are conducted and documented according to standard protocols

Establishment of win-win business cooperation relationships such as clinical and pre-clinical CRO, high-tech medical complex and service platform research, etc

Protect customer intellectual property rights by signing a confidentiality agreement (CDA)


Conduct security training for PI, PM, researchers, and advisors and submit individual security pledges


Using a security platform